Bright Green Corporation (BGXXQ) vs China Pharma Holdings, Inc. (CPHI)

Bright Green Corporation and China Pharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. China Pharma Holdings, Inc. is the larger, with a market value of $31.8M against $13.9M — 2.3× the size. Bright Green Corporation has the higher net margin (0.00% vs −114.3%) and the lower return on invested capital (−39.4% vs −7.23%). Across the 13 metrics below, China Pharma Holdings, Inc. leads on 8 and Bright Green Corporation on 5.

Valuation

Metric BGXXQ CPHI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 7.76 2.25
P/B n/m 0.84 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 8.52 2.56
Earnings yield 0.00% (57.33%) (2.99%)
Free cash flow yield 0.00% (1.10%) 0.00%

Profitability

Metric BGXXQ CPHI Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 11.76% 53.94%
Operating margin 0.00% (111.84%) 0.00%
Net margin 0.00% (114.33%) 0.00%
Free cash flow margin 0.00% (3.59%) 0.00%
Return on equity (73.60%) (20.99%) (0.40%)
Return on assets (44.80%) (15.30%) (3.32%)
Return on invested capital (39.35%) (7.23%) 0.00%

Growth

Metric BGXXQ CPHI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (10.97%) 10.01%
EPS growth (last fiscal year) 58.82% 72.59% —
Revenue growth, 5-year CAGR — (17.53%) 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BGXXQ CPHI Drug Manufacturers Specialty & Generic median
Debt to equity 0.07 0.05 0.05
Current ratio 0.01 0.26 2.31
Net debt to EBITDA (0.02) (0.98) 0.85

Dividend

Metric BGXXQ CPHI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric BGXXQ CPHI Drug Manufacturers Specialty & Generic median
Market cap 13.88m 31.83m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack